Skip to Content

Antibodies, Volume 6, Issue 4

2017 December - 12 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (12)

  • Article
  • Open Access
10 Citations
12,459 Views
19 Pages

Characterization of Monoclonal Antibody–Protein Antigen Complexes Using Small-Angle Scattering and Molecular Modeling

  • Maria Monica Castellanos,
  • James A. Snyder,
  • Melody Lee,
  • Srinivas Chakravarthy,
  • Nicholas J. Clark,
  • Arnold McAuley and
  • Joseph E. Curtis

15 December 2017

The determination of monoclonal antibody interactions with protein antigens in solution can lead to important insights guiding physical characterization and molecular engineering of therapeutic targets. We used small-angle scattering (SAS) combined w...

  • Article
  • Open Access
29 Citations
13,731 Views
15 Pages

12 December 2017

Downstream of pharmaceutical proteins, such as monoclonal antibodies, is mainly done by chromatography, where concentration determination of coeluting components presents a major problem. Inline concentration measurements (ICM) by Ultraviolet/Visible...

  • Article
  • Open Access
4 Citations
7,183 Views
16 Pages

7 December 2017

Clustering of the B cell antigen receptor (BCR) by polyvalent antigens is transmitted through the SYK tyrosine kinase to the activation of multiple intracellular pathways that determine the physiological consequences of receptor engagement. To explor...

  • Article
  • Open Access
11 Citations
7,563 Views
9 Pages

Generation and Performance of R132H Mutant IDH1 Rabbit Monoclonal Antibody

  • Juliet Rashidian,
  • Raul Copaciu,
  • Qin Su,
  • Brett Merritt,
  • Claire Johnson,
  • Aril Yahyabeik,
  • Ella French and
  • Kelsea Cummings

1 December 2017

Isocitrate dehydrogenase 1 (IDH1) gene mutations have been observed in a majority of diffuse astrocytomas, oligodendrogliomas, and secondary glioblastomas, and the mutant IDH1 R132H is detectable in most of these lesions. By specifically targeting th...

  • Article
  • Open Access
27 Citations
10,353 Views
19 Pages

1 December 2017

Substantial improvements have been made to cell culturing processes (e.g., higher product titer) in recent years by raising cell densities and optimizing cultivation time. However, this has been accompanied by an increase in product-related impuritie...

  • Feature Paper
  • Article
  • Open Access
20 Citations
12,014 Views
18 Pages

Pyrrolobenzodiazepine Antibody-Drug Conjugates Designed for Stable Thiol Conjugation

  • R. James Christie,
  • Arnaud C. Tiberghien,
  • Qun Du,
  • Binyam Bezabeh,
  • Ryan Fleming,
  • Amanda Shannon,
  • Shenlan Mao,
  • Shannon Breen,
  • Jing Zhang and
  • Changshou Gao
  • + 4 authors

28 November 2017

Thiosuccinimide-linked antibody-drug conjugates (ADCs) are susceptible to drug loss over time due to a retro-Michael reaction, which can be prevented by selecting stable conjugation positions or hydrolysis of the thiosuccinimide. Here, we investigate...

  • Feature Paper
  • Review
  • Open Access
11 Citations
10,154 Views
14 Pages

Antagonist Anti-CD28 Therapeutics for the Treatment of Autoimmune Disorders

  • Bernard Vanhove,
  • Nicolas Poirier,
  • Fadi Fakhouri,
  • Laetitia Laurent,
  • Bert ’t Hart,
  • Pedro H. Papotto,
  • Luiz V. Rizzo,
  • Masaaki Zaitsu,
  • Fadi Issa and
  • Gilles Blancho
  • + 2 authors

21 November 2017

The effector functions of T lymphocytes are responsible for most autoimmune disorders and act by directly damaging tissues or by indirectly promoting inflammation and antibody responses. Co-stimulatory and co-inhibitory T cell receptor molecules are...

  • Review
  • Open Access
14 Citations
12,637 Views
22 Pages

Monoclonal Antibody: A New Treatment Strategy against Multiple Myeloma

  • Shih-Feng Cho,
  • Liang Lin,
  • Lijie Xing,
  • Tengteng Yu,
  • Kenneth Wen,
  • Kenneth C. Anderson and
  • Yu-Tzu Tai

14 November 2017

2015 was a groundbreaking year for the multiple myeloma community partly due to the breakthrough approval of the first two monoclonal antibodies in the treatment for patients with relapsed and refractory disease. Despite early disappointments, monocl...

  • Review
  • Open Access
22 Citations
9,552 Views
13 Pages

Therapeutic and Diagnostic Antibodies to CD146: Thirty Years of Research on Its Potential for Detection and Treatment of Tumors

  • Jimmy Stalin,
  • Marie Nollet,
  • Françoise Dignat-George,
  • Nathalie Bardin and
  • Marcel Blot-Chabaud

5 November 2017

CD146 (MCAM, MUC18, S-Endo1) is a transmembrane glycoprotein belonging to both CAM and mucin families. It exists as different splice variants and is cleaved from the membrane by metalloproteases to generate a soluble form. CD146 is expressed by numer...

  • Review
  • Open Access
70 Citations
20,685 Views
31 Pages

25 October 2017

Developing therapeutics that induce apoptosis in cancer cells has become an increasingly attractive approach for the past 30 years. The discovery of tumor necrosis factor (TNF) superfamily members and more specifically TNF-related apoptosis-inducing...

  • Feature Paper
  • Article
  • Open Access
10 Citations
8,143 Views
17 Pages

Antibody Selection for Cancer Target Validation of FSH-Receptor in Immunohistochemical Settings

  • Nina Moeker,
  • Solveig Peters,
  • Robert Rauchenberger,
  • Nicolae Ghinea and
  • Christian Kunz

18 October 2017

Background: The follicle-stimulating hormone (FSH)-receptor (FSHR) has been reported to be an attractive target for antibody therapy in human cancer. However, divergent immunohistochemical (IHC) findings have been reported for FSHR expression in tumo...

  • Article
  • Open Access
20 Citations
10,764 Views
13 Pages

Epitope Sequences in Dengue Virus NS1 Protein Identified by Monoclonal Antibodies

  • Leticia Barboza Rocha,
  • Rubens Prince dos Santos Alves,
  • Bruna Alves Caetano,
  • Lennon Ramos Pereira,
  • Thais Mitsunari,
  • Jaime Henrique Amorim,
  • Juliana Moutinho Polatto,
  • Viviane Fongaro Botosso,
  • Neuza Maria Frazatti Gallina and
  • Roxane Maria Fontes Piazza
  • + 7 authors

15 October 2017

Dengue nonstructural protein 1 (NS1) is a multi-functional glycoprotein with essential functions both in viral replication and modulation of host innate immune responses. NS1 has been established as a good surrogate marker for infection. In the prese...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Antibodies - ISSN 2073-4468